3 employees
Regenosca develops biomaterials serving as an alternative to autologous tissue substitutes for soft tissue repair.
2019
$164K
from 2 investors over 2 rounds
Regenosca SA raised $164K on November 12, 2020
Investors: Venture Kick
Regenosca SA raised $41K on April 1, 2020